Mark Krul

Biography

Mark has been involved in anti-cancer drug development since 1993 and has a background in molecular biology and immunology. He obtained a PhD at the University of Utrecht on the development of experimental vaccines against cancer. Prior to co- founding  the Aglaia BioMedical Ventures/Aglaia Oncology Fund in 2003, he was Program Director of the NDDO Research Foundation. He held several positions at NDDO Oncology (formerly the EORTC New Drug Development Office) with respect to oncology drug development strategies (1997-2002). From 1993 – 1997, Mark was Research Manager at the European Cancer Center in Amsterdam. Prior to that, he headed the Department of Molecular Virology at the National Institute of Public Health and Environmental Protection from 1989 - 1993.  

Research Interest

 Oncology